MedTrace Logo

Cranial Electrotherapy Stimulation in the Treatment of Migraine Headaches

NCT01265797 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2015-02-10

Study results available
· View outcomes & findings →

Summary

Cranial electrotherapy stimulation (CES) may be a safe adjunct to medical treatment for pain relief in migraine patients. However, despite the number of CES studies done, many have been open label, single blinded, or have utilized a small group of patients.

Conditions

Interventions

DEVICE

Cranial Electrostimulator

participant wears active cranial electrostimulation device for 20 minutes daily for 28 days

DEVICE

Sham Device

participant wears sham device for 20 minutes daily for 28 days

Sponsors & Collaborators

  • University of Toledo Health Science Campus

    lead OTHER

Principal Investigators

  • Gretchen Tietjen, MD · University of Toledo, HSC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2013-02-28
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01265797 on ClinicalTrials.gov